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Objective: To investigate if introital and vaginal flushing samples inoculated on chromogenic agar could increase
the recoveryrate and rapid identification of Candida and non-albicans species, as compared to cultureof posterior
vaginal fornix samples on Sabouraud agar and speciation of isolates by biochemical tests.
Methods: Samples from the introitus and the posterior vaginal fornix and vaginal lavage samples were collected
from 91 women with a history suggestiveof recurrentvulvovaginal candidosis (RVVC), and with a suspectednew
attack of the condition. The specimens were cultured on Sabouraud and CHROMagar
â. Speciation of yeast
isolates was made on the chromogenic agar by API 32C
® kits and by an atomized system (Vitek
â).
Results: Forty-six(51%)womenwerepositiveforCandidafromoneormoreofthesamples.Theintroitalcultures
were positive in 43 (47%) women, both on Sabouraud and chromogenic agar. From the posterior vaginal fomix,
42 (46%) women were positive on the Sabouraud and 43 (47%) on chromogenic agar cultures,while the vaginal
lavage culturesyieldedCandida on thosetwo media in 40 (44%) and 4l (45%) cases,respectively.Candida albicans
was the most frequent species recovered, from 40 (87%) cases, followed by C. krusei in 4 (9%), C. glabrata in
2 (4%),and C. parapsilosisin one case. There was only onewoman who had a mixed yeast infection, by C. albicans
andC. krusei.Therewasonlyonediscrepancyinthe speciationasdemonstratedbymean ofchromogenicagarand
API 32C kit.
Conclusions: Neither cultures of introital nor of vaginal lavage samples increases the detection rate of Candida in
RVVC cases as compared to cultures of posterior vaginal fornix samples. Use of chromogenic agar is a convenient
and reliable means to detect colonization by Candida and differentiate between C. albicans and non-albicans
species.
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The most common means to diagnose vulvo-
vaginal Candida infections is to study a wet smear
of vaginal secretion that has been treated by
potassiumhydroxide(KOH) forCandida morpho-
types, and/or to culture samples collected with a
cotton-tipped swab from the posterior vaginal
fornix. The specimens can either be sent to a
laboratory for culture and speciation of Candida
isolates or plated on Sabouraud agar directly at the
clinic1–3.
Although the vast majority of strains isolated
from the genital tract in recurrent vulvovaginal
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Clinical study 89candidosis(RVVC) cases belongsto C. albicans4, it
may be essential to identify instances of coloniza-
tion with non-albicans species. Non-albicans strains
have a natural greater resistance to the antifungal
drugs most commonly used to treat vulvovaginal
candidosis (VVC), i.e. various azole drugs5,6. By
the use of chromogenic agar7,8 it is possible to
directlyidentifyanumberofnon-albicansspecies of
Candida by mere inspection of the plates, i.e.
C. albicans, C. tropicalis, and C. krusei, accordingto
the package insert7. Koehler and co-workers9
reported, however, that as many as eight Candida
species could be identified on chromogenic agar.
The species identities on chromogenic agar corre-
spond well to those obtained by fermentation and
assimilation tests10. Apart from use of samples
collected by cotton-tipped swabs, analyses of
vaginal flushing samples have been proved of
value in the diagnosis of genital pathogens11.
A large proportion of women suspected on the
basis of history and clinical examination prove
negativeforCandida oncultureofvaginalposterior
fornix samples. One hypothesis is that analysis of
vaginal lavage samples would increase the chance
of detecting only a low number of Candida organ-
isms in the vagina compared to the most com-
monlyappliedsamplingtechnique,whichinvolves
justtouchingthevaginal mucosawith a swab. This
latter procedure may not leave enough time for
adsorption of yeast organisms by the swab. Even if
rubbing the mucosa, many organisms may remain
attached to the swab material after inoculation of
culture media, resulting in a negative culture.
The present study explored the possibility of
increasing the detection rate of Candida in women
with a history suggestive of RVVC and who did
attend with symptoms and signs that were consis-
tent with a new attack of the condition. Analyses
of introital swab and vaginal lavage samples were
made. Furthermore, the value of chromogenic
agarforcultureofsuchspecimenswasinvestigated.
SUBJECTS AND METHODS
The 91 women recruited to the study had all
attended the outpatient department of the Mater-
nity Hospital 3, Kiev, because of genital symptoms
and a history suggestive of RVVC. They all had
the diagnosis of a genital Candida infection by a
physician at least four times during the previous
year on the basis of history, clinical examination
and at least one positive microscopic test for
Candida morphotypes, in methylene-blue-stained
smears prepared from posterior vaginal fornix
samples. The patients presented with symptoms,
such as vulvovaginal pruritis, irritation, unpleasant
odor and dyspareunia, and/or with dysuria and
burning at micturition. They had signs such as one
or more of edema, erythema, fissures and caseous
discharge.
The vaginal introitus was rubbed with a sterile,
cotton-tipped swab moistened with physiological
saline, which was plated on Sabouraud dextrose
agar (Beckton Dickinson®, Baltimore, USA)3 and
chromogenic agar (CHROMagar®, Paris)9, like
swab samples from the posterior vaginal fornix.
Theorderoftheinoculationonthetwomedia was
changed for each consecutive case studied. There-
after, vaginal lavage fluid was obtained by flushing
the vagina with 3 ml of sterile physiological saline
and by regurgitating the fluid with the aid of
asterile syringe. Ofthemixture, 0.1 mlwasinocu-
lated on each of a Sabouraud and chromogenic
agar plate.
Isolated strains ofCandida were frozenat -70°C
in fetal calf serum for later speciation, which was
done with the aid of API 32C® test kits and an
automized identification system, Vitek® (Bio-
Mérieux, Marcy-l’Etoile, France). Chromogenic
agar plates were read according to the criteria
described by Pfaller and co-workers10.
Thestudywasapprovedbytheethiccommittee
of the Maternity Hospital. Written consents were
obtained from the patients.
RESULTS
Table 1 shows the results of cultures made from
swab samples from the introitus and posterior
vaginal fornix and vaginal lavage samples, inocu-
lated on Sabouraud and chromogenic agar. The
recovery rate from the introitus was the same as
that from the posterior vaginal fornix. The vaginal
lavage samples missed two Candida-positive cases
otherwise diagnosed by the swab samples.
C. albicans was the most frequent isolate,
recovered in 40 (87%) cases, followed by C. krusei
detected in 4 (9%) cases, C. glabrata in two and
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case of mixed Candida infection, i.e. by C. albicans
and C. krusei. The isolation rate on chromogenic
agar was almost the same as on Sabouraudagar: the
differencewas1.4%infavorofchromogenicagar.
A discrepancy in the result of speciation by
means of chromogenic agar versus API 32C kits
was only found in two of the 46 Candida-positive
cases. In these two patients, C. albicans was identi-
fied bytheAPI32C kit,whileC. glabratawas indi-
catedtogrowonthechromogenicagar.Inanother
case, a mixed infection by C. albicans and C. krusei
was found on the chromogenic agar, while only
growth of C. albicans was identified by the API
C32 and Vitek identification methods.
DISCUSSION
The diagnosis of genital Candida infections, in
cases with a history of RVVC who attend with
symptomsandsigns suggestive ofa newattack,fails
more often than generally realized – even if both
microscopic and culture studies are made. Thus
the presence of Candida cannot be confirmed.
Specialists in gynecology often misdiagnose the
condition if not based on patient-close or central
laboratory test results. In a previous study by
Ledger12, the presence of Candida in the genital
tract could only be confirmed in half of cases given
the diagnoses of VVC or RVVC based on history,
clinical examination and patient-close microscopy
of vaginal secretion. In our study, half the women
also proved to be culture-negative for Candida in
spite of a ‘typical’ RVVC case history and findings
at the clinical examination. In another study,
Candida was identified by vaginal cultures in only
28% of 554 women with symptoms consistent
with ‘candidal vaginitis’13. Thus, there are reasons
tobelieve thatacurrentgenitalCandidainfectionis
commonly overdiagnosed in women diagnosed
with RVVC. In fact, those women may suffer
fromothervaginalflorachanges,suchasthoseseen
in bacterial vaginosis (BV)14. Women may switch
between BV and VVC15.
At least 10–15% of all women of reproductive
age are colonized in the vagina by Candida, i.e. are
carriers without any occurrence of either VVC or
RVVC4. This colonization rate adds to the diffi-
culty in diagnosing RVVC exclusively on the basis
of genital yeast cultures,i.e. to differentiate carriers
from cases with a true vaginal mucosal and/or
introital invasion by yeast.
Inourstudy,thesensitivity ofchromogenicagar
compared to Sabouraud dextrose agar for detec-
tion of Candida did not differ (p = 1). This is in
accordance with the findings by Beighton and
co-workers8. Nor did we find the use of vaginal
lavage samples to positively influence the recovery
rate of Candida.
The use of chromogenicagar has one disadvan-
tagecomparedtoSabouraudagar,namely itsrather
high cost. On the other hand, chromogenic agar
can identify most of the species occurring in the
female genitaltract.Consequentlyotherexpensive
identification tests may be avoided. The use of an
incubation temperature below 30°C does not
allow speciation of Candida strains9,16 on chromo-
genic agar. Thus, chromogenic agar cannot be
used at doctors’ offices for speciation if no incuba-
tor is available.
C. albicans, C. krusei and C. tropicalis have been
indicated to represent more than 99% of all yeast
isolates fromthehuman vagina7.Inan Italian study
of symptomatic women with a positive Candida
culture, C. glabrata was the next most common
species found, identified in 1207 of 3351 cases.
C. krusei and C. tropicalis were found in 404 and
290 cases, respectively17. In our study, C. glabrata
was found in only two cases.
The possibility of rapidly identifying the species
of Candida by which a women is colonized
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Number of positive Candida
cultures
Sample type
Sabouraud agar
(n = 91)
Chromogenic agar
(n = 91) p-value
Introital swab
Posterior vaginal
fornix swab
Vaginal lavage
samples
43 (47%)
42 (46%)
40 (44%)
43 (47%)
43 (47%)
41 (45%)
1
1
1
Table 1 Results of swab sample cultures from the
introitus and the posterior vaginal fornix and of vaginal
lavage samples from 91 patients with a history and
current symptoms of recurrent vulvovaginal candidosis
grown on Sabouraud and chromogenic agarincreases the possibility of obtaining successful
cure. Women infected with non-albicans species
may not respond to azole drugs, to which such
species are naturally resistant or have a low sensiti-
vity18. In that respect chromogenic agar serves a
diagnostic purpose in RVVC cases.
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